HTG Molecular Diagnostics Inc is a commercial stage company. It develops & markets a novel technology platform to facilitate the routine use of complex molecular profiling with its focus on clinical applications.
$0.54 -0.03 (-4.85%)
As of 05/26/2022 16:00:00 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.